The presentations will be audio webcast live and available for replay fromDendreon's website, http://www.dendreon.com.
Advertisement
Dendreon Corporation is a biotechnology company whose mission is to targetcancer and transform lives through the discovery, development andcommercialization of novel therapeutics. The Company applies its expertise inantigen identification, engineering and cell processing to produce activecellular immunotherapy product candidates designed to stimulate an immuneresponse. Dendreon is also developing an orally-available small molecule thattargets Trp-p8 that could be applicable to multiple types of cancer as well asbenign prostatic hyperplasia. The Company has its headquarters in Seattle,Washington and is traded on the Nasdaq Global Market under the symbol DNDN.For more information about the Company and its programs, visithttp://www.dendreon.com.Rodman & Renshaw 10th Annual Healthcare Conference New York Palace Hotel Wednesday, November 12, 2008 9:55 a.m. ET Lazard Capital Markets 5th Annual Healthcare Conference The St. Regis Hotel, New York Tuesday, November 18, 2008 8:55 a.m. ET
SOURCE Dendreon Corporation
